Circulating mitochondrial biomarkers in acute coronary syndrome
Mitochondria markers, MOTS-c and PGC-1α, are altered in ACS patients, with no observed sex differences. These findings represent an initial step toward integrating personalized medicine into the clinical management of ACS. Nonetheless, further studies are required to fully elucidate the role of these markers in this pathology.
Authors
- Maria J. Sanchez‐Quintero (ORCID: https://orcid.org/0000-0002-5638-2920)
- José Manuel García‐Pinilla (ORCID: https://orcid.org/0000-0001-5999-5741)
- Almudena Ortega‐Gómez (ORCID: https://orcid.org/0000-0002-3762-6934)
- Ana María Fernández-Ramos
- Ada del Mar Carmona-Segovia (ORCID: https://orcid.org/0000-0002-2031-2760)
- Luis A. García‐Rodríguez (ORCID: https://orcid.org/0000-0002-4655-7483)
- Bélen Sojo
- Manuel F. Jiménez‐Navarro (ORCID: https://orcid.org/0000-0002-6759-0514)
- Ana I. Molina-Ramos
- Andrea Iboleon-Jimenez
Institutions
- Instituto de Salud Carlos III (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Instituto de Investigación Biomédica de Málaga (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-05-15
- DOI
- https://doi.org/10.3389/fmed.2025.1568305
- Citations
- 1
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.81